Asish K. Xavier, PhD
Vice President, Venture Investments Johnson
& Johnson Innovation – JJDC, Inc.
Dr. Xavier is based in the Johnson & Johnson California Innovation Center in South San Francisco, CA. He focuses on venture investments in biotechnology and diagnostics. He joined JJDC in 2004, and has led or co-led investments in over 20 biotech, diagnostics, and medtech deals.
Dr. Xavier previously worked in business development at BioRexis Pharmaceutical Corporation (King of Prussia, PA), which was acquired by Pfizer in 2007. While at BioRexis, he assisted the company in raising a $30 million round of financing. He has worked in business development at Structural GenomiX, Inc. (San Diego, CA), acquired by Eli Lilly in 2008, and was a project leader at Message Pharmaceuticals, Inc. (Malvern, PA).
Dr. Xavier received a PhD in chemical engineering from the University of Houston and an MBA from the Wharton School of the University of Pennsylvania, where he graduated with honors. He received a Bachelor of Technology in chemical engineering from the Indian Institute of Technology, Kanpur, India. He was a postdoctoral research fellow in the Department of Chemistry at the Johns Hopkins University.